Low Risk of Primary Clostridium difficile Infection With Tetracyclines: A Systematic Review and Metaanalysis
Author(s) -
Raseen Tariq,
Janice Cho,
Saloni Kapoor,
Robert Orenstein,
Siddharth Singh,
Darrell S. Pardi,
Sahil Khanna
Publication year - 2017
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cix833
Subject(s) - medicine , clostridium difficile , meta analysis , odds ratio , confidence interval , cohort study , antibiotics , relative risk , randomized controlled trial , medline , microbiology and biotechnology , biology , political science , law
The choice of antibiotics for systemic infections in patients with a high risk of Clostridium difficile infection (CDI) remains a clinical practice dilemma. Although some studies suggest that tetracyclines may be associated with a lower risk of CDI than other antibiotics, other results are conflicting. We conducted a systematic review and metaanalysis of studies that assessed the risk of CDI with tetracyclines compared to other antibiotics.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom